Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Zydus Lifesciences Enters Global CDMO Business by Acquiring Agenus' Biologics Facilities for $75 Million.
Jun 03, 2025•about 1 year ago
Contract Type
agreement
BiotechnologyHealth CarePharmaceutical
Description
Zydus Lifesciences Ltd. has announced its entry into the global biologics CDMO industry by acquiring two manufacturing facilities from Agenus Inc. in California. The acquisition, valued at $75 million upfront and up to $50 million contingent on revenue milestones, positions Zydus as a key player in U.S
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months